Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/29/20
End: 11/14/23
Due: 11/14/24
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 01/20/21
End: 03/03/27
Due: 03/03/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome | NCT04442295 | Stoke Therapeutics, Inc | user2@example.com | None | 2020-06-29 | 2023-11-14 | 2024-11-14 | - | - | 2025-07-14 |
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | NCT06872125 | Stoke Therapeutics, Inc | user2@example.com | None | 2025-06-30 | 2027-08-31 | 2028-08-31 | - | - | 2025-07-14 |
| An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | NCT04740476 | Stoke Therapeutics, Inc | user2@example.com | None | 2021-01-20 | 2027-03-03 | 2028-03-03 | - | - | 2025-07-14 |